Investment Rating - The report gives a "Buy" rating for the cosmetics and medical beauty industry, particularly highlighting the potential of specific companies like Water Sheep Co., Ltd. [13] Core Insights - The cosmetics and medical beauty sector has underperformed the market recently, with the Shenwan Beauty Care Index rising by 1.3% from September 29 to October 10, 2025, which is lower than the overall market performance [3][4] - The upcoming Tmall Double 11 event is expected to boost sales, with domestic brands actively participating with competitive discounts [8] - Water Sheep Co., Ltd. is identified as a leading technology-driven beauty company, with stable revenue projections and improving profit margins [9][10] Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with the Shenwan Cosmetics Index increasing by 1.2%, lagging behind the Shenwan A Index by 0.4 percentage points [3][4] - The top-performing stocks in the sector include Jiaheng Home Care (+35.0%), Yiyi Co., Ltd. (+18.6%), and Yanjing Co., Ltd. (+15.6%) [5] Upcoming Events - Tmall's Double 11 sales event is set to begin on October 15, 2025, with major domestic brands like Proya and Maogeping expected to participate actively [8] Company Focus: Water Sheep Co., Ltd. - Water Sheep Co., Ltd. has a dual business model of proprietary and CP agency brands, with projected revenues stabilizing between 4 to 5 billion yuan from 2021 to 2024 [9] - The company is expected to achieve net profits of 258 million, 331 million, and 398 million yuan for the years 2025, 2026, and 2027, respectively, reflecting significant growth [10][13] Market Trends - The overall retail sales of cosmetics in August 2025 grew by 5.1%, indicating a recovery in consumer demand [17] - The domestic market is seeing a shift in market share, with local brands gaining ground against international competitors [25] E-commerce Insights - Data shows that domestic brands are performing well on platforms like Douyin and Tmall, with significant growth in GMV for brands like Proya and Maogeping [14][15] Company Developments - Proya has filed for an IPO in Hong Kong, with stable revenue growth and a strong online presence [19] - The report highlights the strategic moves of various companies, including partnerships and new product launches, to enhance their market positions [24][23]

Core Viewpoint - The stock price of Ruoyuchen (003010.SZ) has surged significantly, reaching a historical high of 47.36 CNY per share, which is 12.60 times its low of 3.76 CNY at the beginning of 2024, reflecting a cumulative increase of 245.35% as of October 9, 2025. This rise is supported by strong performance in sales and net profit growth, but it also raises concerns about the company's reliance on a few e-commerce platforms and imbalanced marketing and R&D expenditures [1][2][15]. Financial Performance - In 2024, Ruoyuchen achieved sales revenue of 1.766 billion CNY, a year-on-year increase of 29.28%. For the first half of 2025, sales revenue reached 1.319 billion CNY, marking a 67.55% year-on-year growth [1][4]. - The company has experienced a compound annual growth rate (CAGR) of 76.8% in net profit from 2022 to 2024, with a year-on-year increase of 85.60% in the first half of 2025 [1][9]. Brand Development - Ruoyuchen has transitioned from providing e-commerce services to developing its own brands, with significant contributions from its brands "Zhanjia" and "Feicui." The self-owned brand revenue has grown from 13.2% in 2022 to 45.8% in the first half of 2025 [5][6][7]. - The brand "Zhanjia" has achieved cumulative retail sales of 1.6 billion CNY from 2022 to the first half of 2025, with a remarkable year-on-year growth of 175.9% in the first half of 2025 [7][9]. Marketing and R&D Expenditure - The marketing expenditure in the first half of 2025 was over 30 times the R&D expenditure, raising concerns about the sustainability of this spending model. Marketing costs reached 5.99 billion CNY, with a significant portion directed towards online platforms like Douyin [2][11][12]. - R&D spending has remained relatively stable, but its proportion compared to marketing expenses has decreased significantly, indicating a potential risk in innovation and product development [12][13]. Shareholder Actions - The second-largest shareholder, Langzi Co., has been reducing its stake in Ruoyuchen, cashing out over 400 million CNY since the stock price increase began. This reduction in shareholding raises questions about the confidence of institutional investors in the company's future [3][18][20]. - The actual controllers of Ruoyuchen, Wang Yu and Wang Wenhui, have seen their salaries increase by over 50% in the past three years, reflecting the company's financial growth but also potentially raising concerns about executive compensation relative to company performance [16][19]. International Market Presence - As of the first half of 2025, 32.6% of Ruoyuchen's revenue came from overseas markets, indicating a growing international presence and diversification of revenue sources [10][15].

Core Viewpoint - Langzi Co., Ltd. announced that neither the company nor its controlling subsidiaries have experienced overdue guarantees, litigation related to guarantees, or losses due to judgments against them [2] Summary by Category - **Company Status** - Langzi Co., Ltd. confirmed the absence of overdue guarantees [2] - The company reported no involvement in litigation concerning guarantees [2] - There have been no losses incurred from judgments related to guarantees [2]

Core Viewpoint - The company, Langzi Co., has applied for a comprehensive credit limit of 150 million yuan from Ping An Bank's Beijing branch to meet operational funding needs [1] Group 1: Financial Guarantees - Langzi Medical Management, a wholly-owned subsidiary, provides joint liability guarantees for the company [1] - The controlling shareholder, Shen Dongri, and his spouse, Weng Jie, also provide unconditional joint liability guarantees for the company [1] - The total balance of external guarantees provided by the company and its subsidiaries amounts to 1.129 billion yuan, accounting for 40.51% of the audited net assets for the year 2024 [1] Group 2: Off-Balance Sheet Guarantees - The total balance of guarantees for entities outside the consolidated financial statements is 360 million yuan, representing 12.92% [1] - There are no overdue or litigated guarantees reported by the company and its subsidiaries [1] Group 3: Board's Assessment - The board of directors believes that the guarantees align with the interests of the company and its shareholders, posing no negative impact [1]

证券代码：002612 证券简称：朗姿股份 公告编号：2025-062 朗姿股份有限公司 关于全资子公司为公司提供担保并接受关联方担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本次担保在第五届董事会第二十九次会议和 2024 年度股东大会审批额度之 内，无需提交公司董事会、股东会再次审议。 二、被担保人基本情况 朗姿股份 特别提示： 1、朗姿股份有限公司（以下简称"朗姿股份"或"公司"）第五届董事会 第二十九次会议和 2024 年度股东大会分别审议通过了《关于 2025 年度对外担保 额度的议案》，同意 2025 年度公司及其控股子公司的对外担保总额不超过 30.50 亿元（以下除非特别注明，所称"元"均指"人民币元"），其中对资产负债率 未超过 70%的控股子公司担保额度为 24.00 亿元，对资产负债率超过 70%的控股 子公司担保额度为 6.50 亿元。该担保额度的有效期自公司 2024 年度股东大会审 议批准本议案之日起至 2025 年度股东会召开之日止。截至本公告披露日，公司 及控股子公司对外担保总余额为 112,916 万元，占公司 ...

Core Viewpoint - The major shareholder, Langzi Co., Ltd., has completed its share reduction plan for Ruoyuchen Technology Co., Ltd., reducing its stake to approximately 4.36% and officially exiting the list of significant shareholders holding over 5% [1] Group 1: Shareholding Changes - Langzi Co., Ltd. reduced its holdings in Ruoyuchen from over 5% to 4.36%, retaining 13.55 million shares [1] - Langzi Co., Ltd. initially acquired a 20% stake in Ruoyuchen in 2015 for 110 million yuan [2] - Since September 2022, Langzi Co., Ltd. has been continuously reducing its holdings, cashing out nearly 500 million yuan by September 2025 [2] Group 2: Financial Performance - In the first half of 2025, Langzi Co., Ltd. reported a net profit of 274 million yuan, a year-on-year increase of 64.09%, but the profit excluding gains from share reductions was only 136 million yuan, a decrease of 2.70% [2] - Revenue from Langzi Co., Ltd.'s medical beauty business in the first half of 2025 was 1.333 billion yuan, down 6.1% year-on-year, with significant reliance on its Milan Baiyu brand [2] Group 3: Business Operations and Challenges - Langzi Co., Ltd. is actively pursuing acquisitions in the medical beauty sector, recently announcing a cash acquisition of 67.5% of Chongqing Milan Baiyu Shiguang Medical Beauty Hospital for 92.475 million yuan [3] - The company faces significant financial pressure, with short-term loans increasing from 684 million yuan at the beginning of 2024 to 1.314 billion yuan by year-end [4] - Langzi Co., Ltd. is required to pay back taxes and penalties totaling approximately 30.82 million yuan, which is expected to reduce the company's net profit for 2025 by about 3.082 million yuan, representing 15% of the projected net profit for 2024 [4]

Group 1 - The core viewpoint of the news is that the China-South Korea Free Trade Zone concept has experienced a decline of 0.91%, ranking among the top declines in concept sectors, with specific stocks like ST Xinhua Jin hitting the daily limit down [1][3] - The main stocks within the China-South Korea Free Trade Zone concept that saw significant declines include Rizhao Port, Qingdao Food, and Qingdao Port, which contributed to the overall downturn of the sector [1][2] Group 2 - The China-South Korea Free Trade Zone concept faced a net outflow of 0.24 billion yuan in capital today, with nine stocks experiencing net outflows, led by Rizhao Port with a net outflow of 13.43 million yuan [2] - Other notable stocks with significant net outflows include Liao Port Co. with 11.94 million yuan, Qingdao Jinwang with 9.12 million yuan, and Haicheng Bangda with 2.05 million yuan [2] - Conversely, stocks such as Qingdao Double Star, Langzi Co., and Lianyungang saw net inflows of 7.49 million yuan, 6.34 million yuan, and 1.62 million yuan respectively [2]

Market Overview - The apparel and home textile sector experienced a decline of 0.29% on September 30, with Hongxing Co. leading the drop [1] - The Shanghai Composite Index closed at 3882.78, up 0.52%, while the Shenzhen Component Index closed at 13526.51, up 0.35% [1] Top Performers - Anner (002875) saw a significant increase of 8.48%, closing at 18.93, with a trading volume of 187,300 shares and a transaction value of 347 million [1] - Kanglongda (603665) rose by 7.12%, closing at 27.70, with a trading volume of 58,300 shares and a transaction value of 26.65 million [1] - Longtou Co. (600630) increased by 6.62%, closing at 9.18, with a trading volume of 512,900 shares and a transaction value of 469 million [1] Underperformers - Bingshi Co. (001209) experienced a significant drop of 9.84%, closing at 18.78, with a trading volume of 169,200 shares and a transaction value of 324 million [2] - Hongdou Co. (600400) fell by 5.26%, closing at 2.88, with a trading volume of 1,910,300 shares and a transaction value of 561 million [2] - Tianchuang Fashion (603608) decreased by 4.55%, closing at 7.35, with a trading volume of 117,000 shares and a transaction value of 87.46 million [2] Capital Flow - The apparel and home textile sector saw a net outflow of 216 million from institutional investors, while retail investors contributed a net inflow of 186 million [2][3] - Major stocks like Longtou Co. and Haian Home (600398) experienced varying levels of net inflow and outflow from different investor categories [3]

Summary of Key Points Core Viewpoint - Langzi Co., Ltd. has disclosed its total guarantee amount and financial performance, indicating significant leverage and revenue composition across its business segments [1]. Financial Guarantees - The total guarantee amount for the company and its subsidiaries is 1.906 billion yuan, with an external guarantee balance of approximately 1.129 billion yuan, representing 40.51% of the company's audited net assets for 2024 [1]. - The company has provided guarantees totaling 36 million yuan to entities outside the consolidated financial statements, accounting for 12.92% of the audited net assets for 2024 [1]. - The company has a guarantee balance of 10 million yuan for its subsidiary, Beijing Rhine Clothing Co., Ltd., which has a debt-to-asset ratio exceeding 70% [1]. Revenue Composition - For the first half of 2025, the revenue composition of Langzi Co., Ltd. is as follows: - Medical beauty accounts for 47.81% - Fashion women's wear accounts for 35.44% - Green baby products account for 15.6% - Other businesses account for 1.16% [1]. Market Capitalization - As of the report date, Langzi Co., Ltd. has a market capitalization of 7.6 billion yuan [1].

关于为全资子公司提供担保并接受关联方担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：002612 证券简称：朗姿股份 公告编号：2025-060 朗姿股份有限公司 特别提示： 1、朗姿股份有限公司（以下简称"朗姿股份"或"公司"）第五届董事会 第二十九次会议和 2024 年度股东大会分别审议通过了《关于 2025 年度对外担保 额度的议案》，同意 2025 年度公司及其控股子公司的对外担保总额不超过 30.50 亿元（以下除非特别注明，所称"元"均指"人民币元"），其中对资产负债率 未超过 70%的控股子公司担保额度为 24.00 亿元，对资产负债率超过 70%的控股 子公司担保额度为 6.50 亿元。该担保额度的有效期自公司 2024 年度股东大会审 议批准本议案之日起至 2025 年度股东会召开之日止。截至本公告披露日，公司 及控股子公司对外担保总余额为 112,916 万元，占公司 2024 年度经审计净资产 的 40.51%；其中，实际被担保方北京莱茵服装有限公司资产负债率超过 70%， 公司对资产负债率超过 70%的控股子公司担 ...